J&J/AC Immune Potential Alzheimer’s Vaccine's High Dose Shows Promise in Phase 1b/2a Trial

seekingalpha2022-02-15

AC Immune(NASDAQ:ACIU)reported interim 10-week data from a high-dose cohort of a phase 1b/2a trial evaluating ACI-35.030, a phosphorylated-Tau (pTau) vaccine candidate in people with early Alzheimer’s...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Ah Deck
2022-02-16
Ah Deck
Good to know. Pls like
Slee49
2022-02-16
Slee49
OK
calbee_lwh
2022-02-16
calbee_lwh
K
JamesArthur
2022-02-15
JamesArthur
Good news for my granny [What]
Jennifer58
2022-02-15
Jennifer58
Yeah
Anoo
2022-02-15
Anoo
👍

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1188602307?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-02-15 21:57","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1188602307","market":"us","top_or_hot":-1,"title":"J&J/AC Immune Potential Alzheimer’s Vaccine's High Dose Shows Promise in Phase 1b/2a Trial","media":"seekingalpha","content":"<div>\n<p>AC Immune(NASDAQ:ACIU)reported interim 10-week data from a high-dose cohort of a phase 1b/2a trial evaluating ACI-35.030, a phosphorylated-Tau (pTau) vaccine candidate in people with early Alzheimer’s...</p>\n\n<a href=\"https://seekingalpha.com/news/3800050-jjac-immune-potential-alzheimers-vaccines-high-dose-shows-promise-in-phase-1b2a-trial\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J/AC Immune Potential Alzheimer’s Vaccine's High Dose Shows Promise in Phase 1b/2a Trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J/AC Immune Potential Alzheimer’s Vaccine's High Dose Shows Promise in Phase 1b/2a Trial\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 21:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3800050-jjac-immune-potential-alzheimers-vaccines-high-dose-shows-promise-in-phase-1b2a-trial><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AC Immune(NASDAQ:ACIU)reported interim 10-week data from a high-dose cohort of a phase 1b/2a trial evaluating ACI-35.030, a phosphorylated-Tau (pTau) vaccine candidate in people with early Alzheimer’s...</p>\n\n<a href=\"https://seekingalpha.com/news/3800050-jjac-immune-potential-alzheimers-vaccines-high-dose-shows-promise-in-phase-1b2a-trial\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://seekingalpha.com/news/3800050-jjac-immune-potential-alzheimers-vaccines-high-dose-shows-promise-in-phase-1b2a-trial","article_id":"1188602307","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188602307","pubTimestamp":1644933465,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"AC Immune(NASDAQ:ACIU)reported interim 10-week data from a high-dose cohort of a phase 1b/2a trial e","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"J&J/AC免疫潜力阿尔茨海默氏症疫苗的高剂量在1B/2A期试验中显示出希望","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACIU":0.9},"content_text":"AC Immune(NASDAQ:ACIU)reported interim 10-week data from a high-dose cohort of a phase 1b/2a trial evaluating ACI-35.030, a phosphorylated-Tau (pTau) vaccine candidate in people with early Alzheimer’s disease (AD).The company said new interim data showed that the high-dose of ACI-35.030 led to a strong induction of antibodies selective for pTau and its aggregated form, enriched paired helical filaments (ePHF).The company added that the data is consistent with those previously reported for the trial’s mid-dose cohort that showed median anti-pTau antibody titers increasing from baseline by two orders of magnitude at week 2 after a first injection.In addition, results suggested that the induced immune response selectively targets pTau, as shown by an increase in the anti-pTau/anti-Tau IgG ratio over time up to 10 weeks.Median levels of antibodies reactive with pathological Tau (ePHF) were boosted with both the first and second vaccine injections.The company noted that ACI-35.030 continued to be well tolerated with no clinically relevant safety concerns observed in low, mid, high-dose groups.The pTau vaccine is being developed in collaboration with Janssen Pharmaceuticals, a unit of Johnson & Johnson(NYSE:JNJ).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9095543246,"gmtCreate":1644967421394,"gmtModify":1676533980183,"author":{"id":"4098445225447010","authorId":"4098445225447010","name":"Ah Deck","avatar":"https://static.tigerbbs.com/0e52eb1e14e0f630d24f1687ea546cd8","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"4098445225447010","idStr":"4098445225447010"},"htmlText":"Good to know. Pls like","listText":"Good to know. Pls like","text":"Good to know. Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095543246","repostId":1188602307,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095583600,"gmtCreate":1644961790321,"gmtModify":1676533978972,"author":{"id":"3581993357014262","authorId":"3581993357014262","name":"Slee49","avatar":"https://static.tigerbbs.com/a4a9c556617a3ec3446f5c1c667b4aa0","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":5,"crmLevelSwitch":1,"authorIdStr":"3581993357014262","idStr":"3581993357014262"},"htmlText":"OK","listText":"OK","text":"OK","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095583600","repostId":1188602307,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095505512,"gmtCreate":1644940871621,"gmtModify":1676533977985,"author":{"id":"3579950492873390","authorId":"3579950492873390","name":"calbee_lwh","avatar":"https://static.tigerbbs.com/2c71feed0eaf38825c4f2fc86cd7a84d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3579950492873390","idStr":"3579950492873390"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095505512","repostId":1188602307,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095279273,"gmtCreate":1644938035753,"gmtModify":1676533977563,"author":{"id":"3574122255023758","authorId":"3574122255023758","name":"JamesArthur","avatar":"https://static.tigerbbs.com/0230d592c84aee6b78c6136a020bbb52","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3574122255023758","idStr":"3574122255023758"},"htmlText":"Good news for my granny&nbsp;[What]&nbsp;","listText":"Good news for my granny&nbsp;[What]&nbsp;","text":"Good news for my granny [What]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095279273","repostId":1188602307,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095256234,"gmtCreate":1644935908534,"gmtModify":1676533977195,"author":{"id":"3577529300728738","authorId":"3577529300728738","name":"Jennifer58","avatar":"https://static.tigerbbs.com/9a014efda004b6cc112e5d7968adf52f","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3577529300728738","idStr":"3577529300728738"},"htmlText":"Yeah","listText":"Yeah","text":"Yeah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095256234","repostId":1188602307,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095227536,"gmtCreate":1644935131635,"gmtModify":1676533976935,"author":{"id":"3585811450495240","authorId":"3585811450495240","name":"Anoo","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3585811450495240","idStr":"3585811450495240"},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095227536","repostId":1188602307,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":79,"commentSize":6,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1188602307"}